Brown Rudnick LLP

Life Sciences Group, Emerging Growth Companies and Venture Capital Group

Partner

Michael Cohen is co-practice group leader of Brown Rudnick’s Global Life Sciences Group and of the firm’s Emerging Growth Companies & Venture Capital Group. He advises on high-profile matters in the life sciences and technology sectors. Michael's clients regularly rely on him to be a true outside general counsel, ready and able to handle matters big and small as they arise.

Michael represents early stage and mid-market companies in corporate structuring, mergers and acquisitions, joint ventures and strategic alliances, financing transactions, and other general transactional matters at all stages of the corporate life cycle. Michael also advises venture, hedge, and private equity funds, universities, corporate venture groups, and portfolio companies in connection with financing transaction deal terms and stockholders' agreements, technology licensing, corporate governance and securities law compliance in connection with private offerings.

Michael also works closely with Brown Rudnick’s London office in counseling U.K. and European clients engaging in transactions involving U.S. concerns.